PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-22.13%
Negative revenue growth while FSLR stands at 44.39%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
71.96%
Gross profit growth at 50-75% of FSLR's 113.16%. Martin Whitman would question if cost structure or brand is lagging.
139.53%
EBIT growth below 50% of FSLR's 307.03%. Michael Burry would suspect deeper competitive or cost structure issues.
71.69%
Operating income growth under 50% of FSLR's 307.03%. Michael Burry would be concerned about deeper cost or sales issues.
130.29%
Net income growth under 50% of FSLR's 320.03%. Michael Burry would suspect the firm is falling well behind a key competitor.
116.67%
EPS growth under 50% of FSLR's 317.14%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
100.00%
Diluted EPS growth under 50% of FSLR's 314.29%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.06%
Share count expansion well above FSLR's 0.04%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
3.38%
Diluted share count expanding well above FSLR's 0.26%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-311.47%
Negative OCF growth while FSLR is at 40.69%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-447.93%
Negative FCF growth while FSLR is at 158.02%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-71.88%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-42.02%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-53.61%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
14.81%
Positive long-term OCF/share growth while FSLR is negative. John Neff would see a structural advantage in sustained cash generation.
66.29%
Below 50% of FSLR's 842.61%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-34.59%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
24.98%
Positive 10Y CAGR while FSLR is negative. John Neff might see a substantial advantage in bottom-line trajectory.
163.56%
Positive 5Y CAGR while FSLR is negative. John Neff might view this as a strong mid-term relative advantage.
167.47%
Positive short-term CAGR while FSLR is negative. John Neff would see a clear advantage in near-term profit trajectory.
-100.41%
Negative equity/share CAGR over 10 years while FSLR stands at 31.22%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-100.54%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-101.20%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-11.54%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-50.57%
Inventory is declining while FSLR stands at 8.92%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-25.24%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-117.10%
We have a declining book value while FSLR shows 3.20%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-7.17%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-56.68%
Our R&D shrinks while FSLR invests at 2.17%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-36.64%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.